A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma
Celgene
Celgene
Janssen Research & Development, LLC
Otsuka Pharmaceutical Co., Ltd.
National Institutes of Health Clinical Center (CC)
Incyte Corporation
St. Jude Children's Research Hospital
University of California, San Diego
Incyte Corporation
Pfizer
Georgetown University
Regeneron Pharmaceuticals
Dizal Pharmaceuticals
HiberCell, Inc.
Aprea Therapeutics
Oncternal Therapeutics, Inc
Gilead Sciences
Mundipharma Research Limited
ModernaTX, Inc.
Altor BioScience
Altor BioScience
Altor BioScience
Takeda
Stemline Therapeutics, Inc.
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Augusta University
Hoffmann-La Roche
Bayer
Sumitomo Pharma America, Inc.
Roswell Park Cancer Institute
Pfizer
M.D. Anderson Cancer Center
Eisai Inc.
City of Hope Medical Center
pharmaand GmbH
Bristol-Myers Squibb
Bristol-Myers Squibb
Nektar Therapeutics
Takeda
Dana-Farber Cancer Institute
Atara Biotherapeutics
Precision BioSciences, Inc.
H. Lee Moffitt Cancer Center and Research Institute
MedImmune LLC
Molecular Templates, Inc.
Boston Scientific Corporation
Memorial Sloan Kettering Cancer Center
University of Michigan Rogel Cancer Center
Fox Chase Cancer Center